IntegraGen

About:

IntegraGen is a biotechnology company developing molecular markers for central nervous system and metabolic diseases.

Website: http://www.integragen.com

Twitter/X: Integragen

Top Investors: Bank of the Philippine Islands, Idinvest Partners, Amundi Private Equity Funds, Generis Capital Partners, Innovation Capital

Description:

IntegraGen is a French biotech company based on the Genopole life science park in Evry, near Paris. It leverages its unique intellectual property, research expertise and privileged access to sample libraries to develop molecular markers for central nervous system and metabolic diseases. IntegraGen notably uses its proprietary technology platforms to provide genomics services to the pharmaceutical industry, biotech firms and other research providers.

Total Funding Amount:

$14.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Évry, Ile-de-France, France

Founded Date:

2000-01-01

Founders:

Number of Employees:

11-50

Last Funding Date:

2012-07-13

IPO Status:

Public

Industries:

© 2025 bioDAO.ai